NCT04373265 2024-02-23Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)Corcept TherapeuticsPhase 1 Completed15 enrolled
NCT05361083 2022-05-04First-in-human Evaluation of [18F]CETOUppsala UniversityPhase EARLY_PHASE1 Completed20 enrolled
NCT02804750 2019-10-15Study to Evaluate CORT125134 in Participants With Cushing's SyndromeCorcept TherapeuticsPhase 2 Completed35 enrolled 13 charts
NCT03830593 2019-10-10Laparoscopic Adrenalectomy for Large Adrenal Tumors.Samsun Liv HospitalCompleted102 enrolled
NCT00936741 2014-04-02An Extension Study of CORLUX in the Treatment of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed30 enrolled 8 charts
NCT01371565 2014-03-18Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's SyndromeCorcept TherapeuticsPhase 3 Completed4 enrolled 7 charts